Table of Contents Table of Contents
Previous Page  416 / 1082 Next Page
Information
Show Menu
Previous Page 416 / 1082 Next Page
Page Background

S401

ESTRO 36 2017

_______________________________________________________________________________________________

Conclusion

The results of our study show that 3D printing technology

can be used to fabricate patient-specific, large scale

phantoms that could be used for a variety of research,

dosimetric,

and

quality

assurance

purposes.

PO-0766 The effect of air gaps on Magic Plate (MP512)

for small field dosimetry

K. Utitsarn

1

, N. Stansook

1

, Z. Alrowaiili

1

, M. Carolan

2

, M.

Petasecca

1

, M. Lerch

1

, A. Rosenfeld

1

1

University of Wollongong, Center for Medical Radiation

Physics, Wollongong, Australia

2

Wollongong Hospital, Illawara Cancer Care Centre,

Wollongong, Australia

Purpose or Objective

We evaluate the impact of an air gap on the MP512

irradiation response at depth in a phantom and optimize

this gap for accurate small field dosimetry in clinical

photon and electron beams.

Material and Methods

MP512 is a 2 dimensional silicon monolithic detector

manufactured on a p-type substrate. The array consists of

512 pixels with detector size 0.5x0.5 mm

2

and pixel pitch

2 mm. The overall area of the active part of the detector

is 52x52 mm

2

. The output factor (OF) and the percentage

depth dose (PDD) were measured with MP512 in 6MV and

10MV photon beams. The OF was measured at a depth of

10 cm in a solid water phantom for square field sizes

ranging from 0.5 to 10 cm

2

. The PDD was measured for

field sizes 2x2cm

2

, 5x5cm

2

and 10x10cm

2

by scanning the

MP512 from the depth of 0.5 cm to 10 cm. Both the OF and

PDD were measured at all field sizes with an air gap

immediately above the detector of 0.5, 1.0, 1.2, 2.0 and

2.6 mm respectively. The PDD for 6, 12 and 20 MeV

electron beams with a standard applicator providing 10x10

cm

2

field size, were measured using an air gap of 0.5mm

and 2.6mm.

Results

The OF measured by the MP512 reduces with increasing air

gap above the detector. The impact of the air gap is

largest for the small fields of 0.5x0.5 and 1x1 cm

2

while

negligible for field sizes larger than 4x4 cm

2

. The OF

measured by the MP512 detector with an air gap of 0.5 and

1.2 mm show a good agreement with OF measured using

EBT3 film and MO

Skin

for 6 and 10 MV, respectively.

Similar results were observed for the PDD measurements

in field sizes of 5x5 and 10x10 cm

2

. The PDD for a 2x2 cm

2

was within ±3% of the EBT3 for both photon energies. The

PDD measured with MP512 is within ±1.6% and ±1.5% of

that measured using a Markus ionization chamber (IC) for

6 and 10 MV fields respectively. The PDD measured by

electron beams demonstrated no significant effect with

increasing air gap above the MP512 for all energies. The

results for both 0.5mm and 2.6mm gap are within ±3% of

similar measurements made using the Markus IC.

Conclusion

The MP512 response with different air gaps immediately

above the detector in solid water phantom have been

investigated in clinical photon and electron fields. The

results confirm that the MP512 monolithic diode array is

suitable for QA of small fields in a phantom. The study

shows that the air gap size has a significant effect on small

field photon dosimetry performance of the MP512

consistent with a loss of electronic equilibrium. The small

air gap of 0.5 mm and 1.2 mm is the best air gap for small

field dosimetry in 6 and 10 MV photon beams respectively.

The effect of air gap on electron beam dosimetry using the

MP512 was demonstrated to be not significant due to the

electronic equilibrium conditions always being fully

established.

PO-0767 Revisiting EPID design for modern

radiotherapy requirements

P. Vial

1,2

, S. Blake

2,3

, Z. Cheng

2,3

, S. Deshpande

1,4

, S.

Atakaramians

5

, M. Lu

6

, S. Meikle

7

, P. Greer

8,9

, Z. Kuncic

2

1

Liverpool and Macarthur Cancer Therapy Centres and

Ingham Institute, Department of Medical Physics,

Liverpool BC, Australia

2

University of Sydney, Institute of Medical Physics-

School of Physics, Sydney, Australia

3

Ingham Institute, Medical Physics, Liverpool, Australia

4

University of Wollongong, Centre for Medical Radiation

Physics, Wollongong, Australia

5

University of Sydney, Institute of Photonics and Optical

Science- School of Physics, Sydney, Australia

6

Perkin Elmer, Medical Imaging, Santa Clara, USA

7

University of Sydney, Faculty of Health Sciences & Brain

and Mind Centre, Sydney, Australia

8

University of Newcastle, School of Mathematical and

Physicsal Sciences, Newcastle, Australia

9

Calvary Mater Newcastle Hospital, Radiation Oncology,

Newcastle, Australia

Purpose or Objective

New methods of treatment verification that are in keeping

with advances in radiotherapy technology are desirable.

The availability of kilovoltage in-room imaging for

example has led to a general trend away from the poorer

contrast megavoltage (MV) imaging for patient-set-up.

The widespread use of intensity-modulated radiotherapy

(IMRT) also reduces the utility of treatment beams as a

source of imaging for treatment verification. At the same

time there has been a steady increase in the use of

electronic portal imaging devices (EPIDs) for dose

verification. There is however emerging evidence of new

roles for MV imaging in real-time target tracking. In this

work we address the issue of EPID detector specifications

in light of changing clinical requirements. We present a

general overview of the detector development work our

group has undertaken to design an EPID that better

supports applications relevant to current and future

clinical practice.

Material and Methods

Prototype EPID technologies developed by our group

include: a direct detector EPID where the metal/phosphor